AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
Cash Flow PerformanceCompressed
Percentile Rank17
Studio
Year-over-Year Change

Free cash flow yield

Latest
-86.61%
↓ 143% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthCompressed
Average
-35.71%
Historical baseline
PeriodValueYoY Change
2025-86.61%+27.6%
2024-119.66%-985.9%
2023-11.02%+51.9%
2022-22.89%-222.5%
2021-7.10%-281.9%
2020-1.86%-115.8%
2019-0.86%-